JPH0575368B2 - - Google Patents
Info
- Publication number
- JPH0575368B2 JPH0575368B2 JP61105279A JP10527986A JPH0575368B2 JP H0575368 B2 JPH0575368 B2 JP H0575368B2 JP 61105279 A JP61105279 A JP 61105279A JP 10527986 A JP10527986 A JP 10527986A JP H0575368 B2 JPH0575368 B2 JP H0575368B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- tea
- gypsophila
- terpenes
- ginkgo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 244000269722 Thea sinensis Species 0.000 claims description 26
- 241001316290 Gypsophila Species 0.000 claims description 21
- -1 flavone glycosides Chemical class 0.000 claims description 15
- 229930182470 glycoside Natural products 0.000 claims description 15
- 150000003505 terpenes Chemical class 0.000 claims description 10
- 235000007586 terpenes Nutrition 0.000 claims description 10
- 229930003944 flavone Natural products 0.000 claims description 9
- 235000011949 flavones Nutrition 0.000 claims description 9
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 8
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 8
- 241000218628 Ginkgo Species 0.000 claims description 7
- 235000011201 Ginkgo Nutrition 0.000 claims description 7
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 7
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 claims description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 6
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims description 3
- 229930184727 ginkgolide Natural products 0.000 claims description 3
- 235000008777 kaempferol Nutrition 0.000 claims description 3
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempherol Natural products C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims description 3
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 3
- REFJWTPEDVJJIY-UHFFFAOYSA-N quercetin Natural products C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 3
- 235000005875 quercetin Nutrition 0.000 claims description 3
- 229960001285 quercetin Drugs 0.000 claims description 3
- TUGAUFMQYWZJAB-FPLPWBNLSA-N 5-[(8Z)-pentadec-8-enyl]resorcinol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC(O)=CC(O)=C1 TUGAUFMQYWZJAB-FPLPWBNLSA-N 0.000 claims description 2
- SRLTUZDQBFYLQI-FPLPWBNLSA-N Bilobol Natural products Oc1c(CCCCCCC/C=C\CCCCCC)ccc(O)c1 SRLTUZDQBFYLQI-FPLPWBNLSA-N 0.000 claims description 2
- 150000002989 phenols Chemical class 0.000 claims description 2
- 239000002075 main ingredient Substances 0.000 claims 1
- 235000013616 tea Nutrition 0.000 description 19
- 235000019658 bitter taste Nutrition 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 235000006468 Thea sinensis Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 208000006011 Stroke Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000007721 medicinal effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229920001864 tannin Polymers 0.000 description 4
- 239000001648 tannin Substances 0.000 description 4
- 235000018553 tannin Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000020279 black tea Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 235000020333 oolong tea Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 208000013600 Diabetic vascular disease Diseases 0.000 description 1
- 240000008955 Dioscorea japonica Species 0.000 description 1
- 235000005251 Dioscorea japonica Nutrition 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 201000002249 diabetic peripheral angiopathy Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Tea And Coffee (AREA)
Description
産業上の利用分野
本発明は、イチヨウ抽出物の入つた健康茶に関
する。
従来技術並びに問題点
イチヨウは古くから去痰，鎮咳，解毒，治淋，
瀬尿抑制，滋養の効があるとされ、民間薬として
用いられており、ガン，肺結核，タコ，ウオノ目
等の治療にも利用されている。一方、イチヨウ葉
より抽出したエキスには血管拡張，血流増大，血
管系の老化防止，特に脳および皮膚の末梢血流の
改善，精神的症候の改善等の効果があり、脳動脈
硬化，老人ボケ，糖尿病性血管障害，皮膚血行障
害，精神障害等の治療を目的とした現代療法にも
用いられている。
しかしながら、上記のように脳卒中や老人ボケ
の予防並びに治療に効果があるイチヨウ葉抽出エ
キスは、現在、ヨーロツパにおいて医薬品として
用いられているにすぎず、日本国内での利用はほ
とんど検討されていない。一部にこれを健康維持
食品の中に含むと称し販売するようなことが行な
われているが、その香味，風味は決して良いもの
ではなく、食品というよりはむしろ薬品に近いも
のであるばかりか、有効成分とされるフラボン配
糖体やテルペン類の有無も明確ではない。
したがつて、脳卒中や老人ボケの予防並びに治
療のため優れた効果を有するイチヨウ抽出物を含
み、香味，風味が良く、何人も食することが出
来、且つ、有効成分とされるフラボン配糖体やテ
ルペン類を含有し、医療効果の特性を充分に発揮
しうる食品の開発が求められていた。
発明の目的
本発明は、脳卒中や老人ボケの予防並びに治療
のため優れた効果を有するイチヨウ抽出物を含
み、香味，風味が良く、何人も食することが出
来、且つ、有効成分とされるフラボン配糖体やテ
ルペン類を含有し医療効果の特性を充分に発揮し
うる食品の開発を目的とする。
イチヨウ抽出物は強い苦味を有するが、これは
イチヨウ葉中の有効成分とされる、ケルセチン配
糖体，ケンフエロール配糖体等のフラボン配糖体
及び、ギンコライド，ビロバライド等のテルペン
類そのものの苦味に起因する。本発明者等はイチ
ヨウ抽出物入り健康茶を開発するに当り、この苦
味物質による医療効果の特性を維持するととも
に、苦味を適度におさえ、そのほのかな苦味を特
徴とする風味を生かすよう、種々検討し、既に目
的を満足させ得る炭酸飲料の開発に成功してい
る。しかしながら飲用者の中には抽出物に由来す
る苦味に対し、不快感を持つ人もおり、そういつ
た飲用者の嗜好に合う健康飲料を提供する必要が
あつた。
本発明者等は、イチヨウ抽出物の苦味をマスク
するような飲料の開発を目的として検討を重ねた
結果、イチヨウ抽出物の水溶液中にタンニン類を
共存させることにより苦味がマスクされることを
発見した。すなわちサンニン自身の持つ渋味がイ
チヨウ抽出物に由来する苦味に優先するためであ
り、事実、イチヨウ抽出物0.1％〜0.4％を含有す
る水溶液と、それに0.1％のタンニンを加えた水
溶液とを10人のパネラーによる官能試験で比較し
たところ、10人とも前者の場合には苦味、後者の
場合には渋味を感じることがわかつた。本発明者
等はこれにヒントを得、さらにこれを発展させ
て、特定量のイチヨウ抽出物を緑茶，紅茶，麦
茶，ウーロン茶等のタンニン含有飲料に添加せし
め、苦味の和らいだイチヨウ抽出物入り健康飲料
を開発することに成功し、本発明を完成した。
発明の構成
本発明は茶にイチヨウ抽出物を0.1〜５％
（Ｗ／Ｗ）含有させた茶である。本発明のイチヨ
ウ抽出物はギンコイツクアシド，ビロボール等の
低極性フエノールを含有せず、ギンコライド，ビ
ロバライド等のテルペン類、あるいは、ケルセチ
ン配糖体、ケンフエロール配糖体等のフラボン配
糖体のいずれかまたは両者を含むものであり、例
えば、乾燥イチヨウ葉を含水低級アルコールで抽
出した後得られた抽出物より脂溶性有機溶媒を用
いて低極性化合物を除くか、あるいはさらに、水
と混和しない有機溶媒により抽出するといつた公
知の方法により製造することができる。抽出物中
のフラボン配糖体やテルペン類の定性確認、並び
に定量は薄層クロマトグラフイーや高速液体クロ
マトグラフイーによつて容易に行なうことができ
る。
本発明に用いられるイチヨウ抽出物は、例え
ば、次のようにして作ることが出来る。まず、イ
チヨウ葉を含水エタノール中で加熱還流し、葉を
別して得られるエタノール溶液を濃縮し、その
濃縮物に蒸留水とクロロホルムを加えてクロロホ
ルム可溶部を除き、水層をメチルエチルケトンで
抽出する。抽出物にエタノールを加え不溶物を除
いた後、エタノールを濃縮乾固してイチヨウ葉抽
出物とする。
本発明に用いられる茶としては緑茶，紅茶，麦
茶，ウーロン茶等の茶類の浸出液あるいは、同茶
類の粉末などである。
本発明の実施の態様としては茶類の浸出液にイ
チヨウ抽出物を配合した液状の健康茶、あるいは
茶類の粉末と混合しテイーバツク形態で提供する
ことも出来る。
本発明においては、苦味をおさえ、且つ、医療
効果を発揮させるために、イチヨウ抽出物の添架
割合を、茶類の粉末に対し0.1〜５％（Ｗ／Ｗ）
に調整する。なお、イチヨウ抽出物中のフラボン
配糖体やテルペン類は溶解性が良いので最終製品
中で分離することはない。
発明の効果
このようにして製造されたイチヨウ抽出物入り
健康茶には、フラボン配糖体やテルペン類の苦味
成分が含まれており、脳卒中や老人ボケの予防や
治療効果が期待できる。しかもイチヨウ抽出物の
苦味が、茶類の浸出液中に含まれるタンニン類に
よりマスクされるため、イチヨウ抽出物に由来す
る苦味を良しとしない飲用者にも満足され得るも
のとなつた。
実施例
次に実施例と、その製品の風味試験の結果を示
す。
実施例 １〜３
緑茶，紅茶，麦茶，ウーロン茶の粉末、各2g
と第１表に示した量のイチヨウ抽出物を混合して
テイーバツクとし、90℃以上の熱湯150mlの入つ
たカツプ中でこれを浸出させ浸出液を得た。
比較例１〜４として、実施例１〜４と同量のイ
チヨウ抽出物を含有する水溶液、及び比較例５〜
８として異性化糖５％とシヨ糖0.5％を加えた水
溶液に実施例１〜４と同量のイチヨウ抽出物添加
した溶液を作り風味試験を行つた。
風味試験は実施例１〜４及び、比較例１〜８に
つき10名のパネラーによる官能テストで行ない、
それぞれイチヨウ抽出物を含まないコントロール
に比べ強い苦味を覚えるか否かを判定した。結果
を第２表に示す。表中の数字はコントロールに比
べ強い苦味を感じたパネラーの人数を示す。
この試験結果から、イチヨウ抽出物は茶類の浸
出液中に溶解させることによりその苦味を和らげ
ることが出来、したがつてこれより成るイチヨウ
抽出物入り健康茶は苦味を良しとしない飲用者に
も充分提供しうるものであることが判つた。
INDUSTRIAL APPLICATION FIELD The present invention relates to a health tea containing a Gypsophila extract. Conventional technology and problems Gypsophila has been used as an expectorant, antitussive, detoxifier, and healing agent since ancient times.
It is said to have the effect of suppressing urination and being nourishing, and is used as a folk medicine, and is also used to treat cancer, pulmonary tuberculosis, calluses, and urticaria. On the other hand, the extract extracted from Ginkgo leaves has the effect of dilating blood vessels, increasing blood flow, preventing aging of the vascular system, improving peripheral blood flow in the brain and skin in particular, and improving mental symptoms. It is also used in modern therapy to treat blurred vision, diabetic vascular disorders, cutaneous blood circulation disorders, and mental disorders. However, as mentioned above, the Gypsophila leaf extract, which is effective in the prevention and treatment of stroke and senility, is currently only used as a medicine in Europe, and its use in Japan has hardly been considered. In some cases, this product is sold under the guise that it is included in health maintenance foods, but its flavor and aroma are not at all good, and it is more like a medicine than a food. It is also not clear whether or not there are flavone glycosides and terpenes, which are said to be active ingredients. Therefore, flavone glycosides, which contain Gypsophila extract, which has excellent effects for the prevention and treatment of stroke and senility, have good flavor and flavor, can be eaten by many people, and are considered to be active ingredients. There has been a demand for the development of foods that contain terpenes and terpenes and can fully exhibit the characteristics of medical effects. Purpose of the Invention The present invention provides an extract that contains a Gypsophila extract that has excellent effects for the prevention and treatment of stroke and senility, has a good flavor and flavor, can be eaten by many people, and contains flavones as an active ingredient. The aim is to develop foods that contain glycosides and terpenes and can fully exhibit the characteristics of medical effects. Gulp extract has a strong bitter taste, but this is due to the bitterness of flavone glycosides such as quercetin glycosides and kaempferol glycosides, and terpenes such as ginkgolide and bilobalide, which are said to be the active ingredients in Gulp leaves. to cause. In developing a health tea containing Ginkgo extract, the present inventors conducted various studies in order to maintain the medical effects of this bitter substance, suppress the bitterness to an appropriate level, and make use of the flavor characterized by its faint bitterness. However, they have already succeeded in developing a carbonated drink that satisfies the purpose. However, some drinkers are uncomfortable with the bitter taste derived from the extract, and there is a need to provide a health drink that suits the tastes of such drinkers. As a result of repeated studies with the aim of developing a beverage that would mask the bitterness of Gypsophila extract, the present inventors discovered that the bitterness could be masked by coexisting tannins in an aqueous solution of Gypsophila extract. did. In other words, the astringency of the sunnin itself takes precedence over the bitterness derived from the Japanese yam extract.In fact, an aqueous solution containing 0.1% to 0.4% of the yam extract and an aqueous solution with 0.1% tannin added to it are mixed for 10 minutes. When compared in a sensory test conducted by a human panel, all 10 people found that the former taste was bitter, while the latter was astringent. The present inventors took a hint from this and developed it further by adding a specific amount of glutinous extract to tannin-containing beverages such as green tea, black tea, barley tea, and oolong tea, and created a health drink containing glutinous extract with a less bitter taste. They succeeded in developing this and completed the present invention. Structure of the invention The present invention adds 0.1 to 5% of Gypsophila extract to tea.
(W/W). The Ginkgo extract of the present invention does not contain low polar phenols such as ginkgo tsuquaside and bilobol, but contains either terpenes such as ginkgolide and bilobalide, or flavone glycosides such as quercetin glycoside and kaempferol glycoside. Or, it contains both, for example, by extracting dried fig leaves with a water-containing lower alcohol, and then removing low polar compounds from the extract using a fat-soluble organic solvent, or in addition, using an organic solvent that is immiscible with water. It can be produced by a known method such as extraction. Qualitative confirmation and quantitative determination of flavone glycosides and terpenes in the extract can be easily performed by thin layer chromatography or high performance liquid chromatography. The Gypsophila extract used in the present invention can be produced, for example, as follows. First, Ginkgo leaves are heated to reflux in aqueous ethanol, the leaves are separated, the resulting ethanol solution is concentrated, distilled water and chloroform are added to the concentrate to remove the chloroform-soluble portion, and the aqueous layer is extracted with methyl ethyl ketone. Ethanol is added to the extract to remove insoluble matter, and the ethanol is concentrated to dryness to obtain a fig leaf extract. The tea used in the present invention includes infusions of teas such as green tea, black tea, barley tea, and oolong tea, or powders of the same teas. As an embodiment of the present invention, it is also possible to provide a liquid health tea in which a tea infusion solution is mixed with a Gypsophila extract, or in the form of a tea bag by mixing it with a tea powder. In the present invention, in order to suppress bitterness and exhibit medical effects, the addition ratio of Gypsophila extract to tea powder is 0.1 to 5% (W/W).
Adjust to. In addition, the flavone glycosides and terpenes in the Gypsophila extract have good solubility, so they will not be separated in the final product. Effects of the Invention The health tea containing Gypsophila extract produced in this way contains bitter components such as flavone glycosides and terpenes, and is expected to have preventive and therapeutic effects on stroke and senility. Moreover, since the bitter taste of the fig extract is masked by the tannins contained in the tea infusion, it can be satisfied even by drinkers who do not like the bitter taste derived from the fig extract. Examples Next, examples and the results of flavor tests of the products will be shown. Examples 1-3 Green tea, black tea, barley tea, oolong tea powder, 2g each
and Gypsophila extract in the amount shown in Table 1 were mixed to make a tea bag, and this was leached in a cup containing 150 ml of boiling water at 90°C or higher to obtain an infusion solution. Comparative Examples 1 to 4 are aqueous solutions containing the same amount of Gypsophila extract as Examples 1 to 4, and Comparative Examples 5 to 4.
As Example 8, a solution was prepared by adding the same amount of Gypsophila extract as in Examples 1 to 4 to an aqueous solution containing 5% high fructose sugar and 0.5% sucrose, and a flavor test was conducted. The flavor test was conducted by a sensory test by 10 panelists for Examples 1 to 4 and Comparative Examples 1 to 8.
It was determined whether or not each sample had a stronger bitter taste compared to a control that did not contain Gypsophila extract. The results are shown in Table 2. The numbers in the table indicate the number of panelists who felt a stronger bitterness than the control. From this test result, it was found that the bitterness of the Gypsophila extract can be alleviated by dissolving it in tea infusions, and that the health tea containing the Gypsophila extract made from this can be sufficiently provided to drinkers who do not like the bitter taste. It turned out that it was possible.
【表】【table】
Claims (1)
含有させたことを特徴とするイチヨウ抽出物入り
健康茶。 ２ イチヨウ抽出物が、ギンコイツクアシド，ビ
ロボール等の低極性フエノールを含有せず、ギン
コライド，ビロバライド等のテルペン類、あるい
は、ケルセチン配糖体、ケンフエロール配糖体等
のフラボン配糖体のいずれか、または両者を主成
分として含有することを特徴とする特許請求の範
囲第１項記載のイチヨウ抽出物入り健康茶。[Claims] 1. 0.1 to 5% (W/W) of Gypsophila extract in tea
Healthy tea containing fig extract. 2. Ginkgo extract does not contain low polar phenols such as ginkgo tsuquaside and bilobol, and contains either terpenes such as ginkgolide or bilobalide, or flavone glycosides such as quercetin glycoside or kaempferol glycoside, The health tea containing Gypsophila extract according to Claim 1, characterized in that it contains either or both as main ingredients.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10527986A JPS62262947A (en) | 1986-05-08 | 1986-05-08 | Health tea containing ginkgo extract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10527986A JPS62262947A (en) | 1986-05-08 | 1986-05-08 | Health tea containing ginkgo extract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62262947A JPS62262947A (en) | 1987-11-16 |
| JPH0575368B2 true JPH0575368B2 (en) | 1993-10-20 |
Family
ID=14403231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10527986A Granted JPS62262947A (en) | 1986-05-08 | 1986-05-08 | Health tea containing ginkgo extract |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62262947A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0249544A (en) * | 1988-08-11 | 1990-02-19 | Nonogawa Shoji:Kk | Ginkgo ingredient-containing food and drink |
| CN1054028C (en) * | 1993-07-23 | 2000-07-05 | 邱芳龙 | Health tea added with gingko nut and pueraria root extract |
| KR100385311B1 (en) * | 2000-10-11 | 2003-05-23 | 박화목 | Process for preparing ginkgo-tea and ginkgo-tea prepared thereby |
| CN102578322B (en) * | 2012-02-21 | 2013-06-05 | 徐州绿之野生物食品有限公司 | Ginkgo oolong tea and preparation method thereof |
| CN102613348A (en) * | 2012-04-17 | 2012-08-01 | 徐州绿之野生物食品有限公司 | Ginkgo biloba oolong tea and preparation method of ginkgo biloba oolong tea |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5237079A (en) * | 1975-09-18 | 1977-03-22 | Matsushita Electric Ind Co Ltd | Impedance measuring device |
-
1986
- 1986-05-08 JP JP10527986A patent/JPS62262947A/en active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5237079A (en) * | 1975-09-18 | 1977-03-22 | Matsushita Electric Ind Co Ltd | Impedance measuring device |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62262947A (en) | 1987-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Valduga et al. | Chemistry, pharmacology and new trends in traditional functional and medicinal beverages | |
| CN108815377B (en) | Processing method for steamed rhizoma polygonati | |
| TWI328428B (en) | Packaged beverages | |
| CN102552462B (en) | Effervescent preparation as well as preparation method and application thereof | |
| JP4742752B2 (en) | Beverage production method | |
| JP4248571B2 (en) | Flavor improving agent, flavor improving method using the same, and food and drink | |
| JP4679362B2 (en) | Preparation method of tea extract | |
| JP3131448B2 (en) | Ginseng method and processed ginseng produced by it | |
| Suna et al. | Trends and possibilities of the usage of medicinal herbal extracts in beverage production | |
| JPH0575368B2 (en) | ||
| CN103181437A (en) | Apocynum venetum tea drink | |
| JP4037035B2 (en) | Flavor improver | |
| CN104256024A (en) | Blood-fat-reducing coffee | |
| JPH0563147B2 (en) | ||
| JPH04158771A (en) | Method for improving taste of tea and herb, etc., with coffee and drinking composition | |
| US2115411A (en) | Preparation of yerba mate | |
| RU2612779C2 (en) | Beverage concentrate (versions) | |
| JPH0550254B2 (en) | ||
| CN106720755A (en) | A kind of corn stigma bitter leaves tea beverage and preparation method thereof | |
| KR101759965B1 (en) | A process for the preparation of saengmaekssan beverage having improved sensuality and the saengmaekssan beverage prepared therefrom | |
| JP3159543B2 (en) | Ginseng extract purification method and ginseng-containing beverage | |
| KR0139381B1 (en) | Health drinks including green tea | |
| KR100395464B1 (en) | Novel extraction method of Catechin and Catechin containing drinks using this method | |
| JP2000139392A (en) | Method for processing ginkgo leaf and product of ginkgo leaf processed by the method | |
| KR20040094961A (en) | Composition of herb tea powder, coffee powder, greentea powder for anti-obeseness and liquid thereof |